Stockreport

Theravance Biopharma, Inc. Reports Record Fourth Quarter and Full Year 2024 Financial Results [Yahoo! Finance]

Theravance Biopharma, Inc. - Ordinary Shares  (TBPH) 
Last theravance biopharma, inc. - ordinary shares earnings: 2/24 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.theravance.com/investor-relations
PDF FY 2024 TRELEGY Net Sales, as reported by GSK, of $3.46 billion , up 26% compared with 2023 and triggering a $50 million milestone to Theravance Biopharma CYPRESS stu [Read more]